The efficacy of oral transmucosal fentamyl as an analgesic agent during pan retinal photocoagulation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN27801757

Enrollment

Registered

2007-09-28

Start date

2006-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy Eye Diseases Retinal diseases

Interventions

Please note that, as of 09/05/2008, the start and anticipated end dates of this trial were updated from 01/05/2006 and 01/08/2007 to 01/09/2006 and 01/12/2007, respectively. Interventions amended as

Eligibility

Inclusion criteria

Inclusion criteria: Added as of 09/05/2008: 1. Both males and females 2. Patients undergoing pan retinal photocoagulation (PRP) for any reason: 2.1. Pan retinal/ sectoral 2.2. One/ both eyes NB: Previous laser treatment to the same eye is not an exclusion criteria

Exclusion criteria

Exclusion criteria: Added as of 09/05/2008: 1. Age <18 years 2. Morphine/ codeine allergy 3. Chronic obstructive pulmonary disease/ emphysema 4. Mental incapability to provide informed consent 5. Concomitant or recent (within 2 weeks) use of monoamine oxidase inhibitors (MAOIs)

Design outcomes

Primary

Measure	Time frame
Added as of 09/05/2008: 1. Visual analogue pain score (100 mm) for each patient, after each laser treatment session 2. Side effect questionnaire for each patient, after each laser treatment session	—

Secondary

Measure	Time frame
Added as of 09/05/2008: 1. Calculation of the mean and standard deviation of outcome measurements	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026